🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AL2846 is a multi-target receptor tyrosine kinase inhibitor. The purpose of...
Status
Terminated
Location
Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University
Start Date
2021-09-07
Trial ID
NCT05011019
Treatments Being Tested
The goal of this clinical trial is to learn if the study drug can treat in ...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2026-04-01
Trial ID
NCT07638891
Treatments Being Tested
An open-label, multicenter, phase Ia/Ib study to evaluate the safety, toler...
Status
Unknown
Location
Guangdong Provincial People's Hospital
Start Date
2021-04-28
Trial ID
NCT04708210
Treatments Being Tested
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University
Start Date
2024-10-03
Trial ID
NCT06825624
Treatments Being Tested
This is a a Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation a...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-02-03
Trial ID
NCT04178460
Treatments Being Tested
This study is a multi-center, open-label, dose-esclation I/Ib clinical stud...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2017-09-06
Trial ID
NCT04103853
Treatments Being Tested
A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Start Date
2022-05-10
Trial ID
NCT05109728
Treatments Being Tested
The objective of this extension study is the initial assessment of safety a...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-29
Trial ID
NCT02690181
Treatments Being Tested
This phase Ib trial investigates the side effects and how well a shorter co...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-08-11
Trial ID
NCT04523818
Treatments Being Tested
Phase Ib, single centre, double-blind, double-dummy placebo-controlled, ran...
Status
Completed
Location
Hospital Universitario "Dr. José Eleuterio González" de la Universidad Autónoma de Nuevo León.
Start Date
2020-10-23
Trial ID
NCT04440774